RESMED INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Resmed Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
Resmed Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $65.5M, a 38.9% increase year-over-year.
Resmed Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $244M, a 19.5% increase year-over-year.
Resmed Inc annual Income Tax Expense (Benefit) for 2024 was $244M, a 19.5% increase from 2023.
Resmed Inc annual Income Tax Expense (Benefit) for 2023 was $204M, a 12.7% increase from 2022.
Resmed Inc annual Income Tax Expense (Benefit) for 2022 was $181M, a 55.8% decline from 2021.

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$244M	$65.5M	+$18.4M	+38.9%	Apr 1, 2024	Jun 30, 2024	10-K	2024-08-09
Q1 2024	$225M	$74.9M	+$18.1M	+31.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-26
Q4 2023	$207M	$50.7M	+$1.88M	+3.85%	Oct 1, 2023	Dec 31, 2023	10-Q	2024-01-25
Q3 2023	$206M	$52.8M	+$1.45M	+2.83%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-10-27
Q2 2023	$204M	$47.1M	+$4.11M	+9.55%	Apr 1, 2023	Jun 30, 2023	10-K	2024-08-09
Q1 2023	$200M	$56.9M	+$9.57M	+20.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-26
Q4 2022	$190M	$48.8M	+$13.2M	+37.3%	Oct 1, 2022	Dec 31, 2022	10-Q	2024-01-25
Q3 2022	$177M	$51.3M	-$3.86M	-7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-27
Q2 2022	$181M	$43M	-$1.08M	-2.45%	Apr 1, 2022	Jun 30, 2022	10-K	2024-08-09
Q1 2022	$182M	$47.3M	-$249M	-84%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-28
Q4 2021	$431M	$35.5M	+$4.46M	+14.3%	Oct 1, 2021	Dec 31, 2021	10-Q	2023-01-27
Q3 2021	$427M	$55.2M	+$17.7M	+47.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-28
Q2 2021	$409M	$44.1M	+$9.85M	+28.8%	Apr 1, 2021	Jun 30, 2021	10-K	2023-08-11
Q1 2021	$399M	$296M	+$268M	+940%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-29
Q4 2020	$131M	$31.1M	+$12.9M	+70.8%	Oct 1, 2020	Dec 31, 2020	10-Q	2022-01-28
Q3 2020	$118M	$37.5M	+$7.04M	+23.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-29
Q2 2020	$111M	$34.3M	+$7.3M	+27.1%	Apr 1, 2020	Jun 30, 2020	10-K	2022-08-12
Q1 2020	$104M	$28.5M	-$4M	-12.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-30
Q4 2019	$108M	$18.2M	-$3.44M	-15.9%	Oct 1, 2019	Dec 31, 2019	10-Q	2021-01-29
Q3 2019	$112M	$30.4M	-$2.71M	-8.16%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-30
Q2 2019	$114M	$27M	-$4.14M	-13.3%	Apr 1, 2019	Jun 30, 2019	10-K	2021-08-17
Q1 2019	$118M	$32.5M	+$12.5M	+62.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	$106M	$21.6M	-$111M	-83.6%	Oct 1, 2018	Dec 31, 2018	10-Q	2020-01-31
Q3 2018	$217M	$33.1M	+$10.8M	+48.2%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-25
Q2 2018	$206M	$31.1M	+$11.1M	+55.5%	Apr 1, 2018	Jun 30, 2018	10-K	2020-08-13
Q1 2018	$195M	$20M	-$149K	-0.74%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-03
Q4 2017	$195M	$132M	+$113M	+579%	Oct 1, 2017	Dec 31, 2017	10-Q	2019-02-01
Q3 2017	$82M	$22.4M	+$5.54M	+33%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-26
Q2 2017	$76.5M	$20M	-$14.3M	-41.7%	Apr 1, 2017	Jun 30, 2017	10-K	2019-08-08
Q1 2017	$90.8M	$20.2M	+$1.96M	+10.8%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-04-27
Q4 2016	$88.8M	$19.5M	+$1.35M	+7.42%	Oct 1, 2016	Dec 31, 2016	10-Q	2018-01-24
Q3 2016	$87.4M	$16.8M	+$291K	+1.76%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-27
Q2 2016	$87.2M	$34.3M	+$17.7M	+106%	Apr 1, 2016	Jun 30, 2016	10-K	2018-08-17
Q1 2016	$69.5M	$18.2M	-$5.17M	-22.1%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-04-28
Q4 2015	$74.7M	$18.1M	-$6.21M	-25.5%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-01-25
Q3 2015	$80.9M	$16.5M	-$2.14M	-11.5%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-28
Q2 2015	$83M	$16.7M	-$2.24M	-11.9%	Apr 1, 2015	Jun 30, 2015	10-K	2017-08-04
Q1 2015	$85.3M	$23.4M	+$432K	+1.88%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-04-29
Q4 2014	$84.8M	$24.3M	+$1.51M	+6.59%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-01-28
Q3 2014	$83.3M	$18.7M	-$2.47M	-11.7%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-10-27
Q2 2014	$85.8M	$18.9M	+$4.08M	+27.6%	Apr 1, 2014	Jun 30, 2014	10-K	2016-08-05
Q1 2014	$81.7M	$22.9M	-$136K	-0.59%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-29
Q4 2013	$81.9M	$22.8M	+$2.37M	+11.6%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-01-30
Q3 2013	$79.5M	$21.1M	+$1.5M	+7.66%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-31
Q2 2013	$78M	$14.8M	-$6.85M	-31.6%	Apr 1, 2013	Jun 30, 2013	10-K	2015-08-07
Q1 2013	$84.8M	$23.1M	+$3.69M	+19%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-01
Q4 2012	$81.2M	$20.5M	+$399K	+1.99%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-01-29
Q3 2012	$80.8M	$19.6M	+$3.66M	+22.9%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-10-30
Q2 2012	$77.1M	$21.7M	+$2.93M	+15.6%	Apr 1, 2012	Jun 30, 2012	10-K	2014-08-08
Q1 2012	$74.2M	$19.4M	+$1.72M	+9.74%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-01
Q4 2011	$72.4M	$20.1M	-$406K	-1.98%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-01-31
Q3 2011	$72.9M	$16M	-$3.87M	-19.5%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-10-31
Q2 2011	$76.7M	$18.7M			Apr 1, 2011	Jun 30, 2011	10-K	2013-08-13
Q1 2011		$17.7M	-$1.15M	-6.12%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-01
Q4 2010		$20.5M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-02
Q3 2010		$19.8M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-03
Q1 2010		$18.8M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.